Prevalence and impact of sarcopenia and frailty in inflammatory bowel disease, and the effect of multi-modal interventions on sarcopenia and clinical outcomes in patients with inflammatory bowel disease - NI

All India Institute of Medical Sciences0 个研究点目标入组 0 人开始时间: 待定最近更新: 2024年1月22日

试验速览

暂无简介。

•Inclusion Criteria (First phase)
•1)Age between 18 years to 65 years
•2)Patients with aggressive IBD as defined above
•3)Provide informed consent
•Inclusion Criteria (Second phase)
•1)Patients found to be having sarcopenia during first phase of the study randomized into intervention arm and standard treatment arm
•2)Provide informed consent

•Exclusion Criteria (First phase)
•1)Patients with other comorbid illnesses (end stage liver, kidney, cardiac illnesses, neuromuscular illnesses and terminal cancer patients)
•2)Pregnancy and Lactation
•Exclusion Criteria (Second phase)
•1)Patients with other comorbid illnesses (end stage liver, kidney, cardiac illnesses, neuromuscular illnesses and terminal cancer patients)
•2)Pregnancy and lactation
•3)Inability to perform exercise
•4)Inability to adhere to prescribed diet / nutritional supplements
•5)Patients requiring surgery
•6)Patients enrolled in other trials

发起方